腹主动脉瘤腔内修复术后髂支移位的易感因素与再干预
该研究通过4例EVAR术后髂支移位病例,分析移位相关因素,包括大动脉瘤(>60mm)、髂总动脉扩张(>18mm)、固定长度短(<70%)、髂支放大不足(<10-20%)及喇叭口型支架。所有患者通过额外植入髂支架成功治疗,无围术期死亡或并发症。
要点
- 动脉瘤直径>60mm、髂总动脉>18mm、固定长度<70%增加髂支移位风险
- 髂支放大<10-20%及喇叭口型支架与移位相关
- 额外植入支架是有效且常见的再干预方式
核心结论
- EVAR术后髂支移位受大动脉瘤、髂总动脉扩张、固定长度短、放大不足及喇叭口支架等多因素影响。
- 额外植入髂支架是有效且最常见的再干预方式。
研究设计与样本
- 回顾性病例系列,纳入2012年4月至2017年9月共4例EVAR术后髂支移位患者。
主要发现
- 4例患者均发生髂支移位,其中2例为破裂性腹主动脉瘤。
- 移位的髂总动脉平均直径25.50±11.1 mm,平均长度32.8±6.6 mm,平均比例锚定率72.75%±17.88%。
- 髂支架放大率2例为10-20%,另2例<10%。
- 移位的髂支均为喇叭口型支架。
- 所有患者成功接受额外髂支架植入,围术期无死亡或并发症,随访7个月至3年情况良好。
关键数值与推荐
- 动脉瘤直径>60 mm。
- 髂总动脉直径>18 mm或呈瘤样扩张。
- 固定长度<70%。
- 髂支放大程度<10-20%。
- 喇叭口型髂支。
临床怎么用
- 对存在大动脉瘤、髂总动脉扩张、固定长度短、放大不足或使用喇叭口支架的患者,EVAR术后应加强监测。
- 发生髂支移位时,额外植入髂支架是有效且常用的再干预方法。
局限性
- 样本量小(仅4例),为单中心回顾性研究,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Migration of the iliac limb after endovascular abdominal aortic aneurysm repair (EVAR) can result in type 1b and 3 endoleaks, which are relatively common causes of reintervention after EVAR. The aim of the present study was to investigate the factors influencing migration of the iliac limb and methods of treatment. METHODS: From April 2012 to September 2017, 4 patients experienced migration of the iliac limb, requiring additional iliac stent graft implantation intraoperatively or at follow-up at our institute. Patient 1 was a 74-year-old man in whom preoperative computed tomography angiography (CTA) revealed a large aneurysm. The patient underwent EVAR with a bifurcated stent graft, and the left iliac stent graft migrated into the aneurysm sac. Patient 2 was a 53-year-old man in whom CTA revealed a large abdominal aortic aneurysm (AAA) involving the bilateral common iliac artery (CIA), with occlusion of the left hypogastric artery. An iliac stent graft was deployed to the right CIA to preserve the hypogastric artery. CTA, at 5 years of follow-up, showed migration of the right iliac limb and impending rupture. Patient 3 was a 61-year-old man with a ruptured AAA, and CTA revealed a large AAA and dilated CIA. The patient underwent EVAR with a bifurcated stent graft. Three years after EVAR, CTA showed that the right iliac limb migrated and kinked, with rupture of the stent graft. Patient 4 was an 80-year-old man with a ruptured AAA and aortocaval fistula. CTA revealed a large aneurysm involving the bilateral CIA. The patient underwent urgent EVAR with a bifurcated stent graft, and a cuff was deployed to seal the landing zone of the left CIA to preserve the hypogastric artery. Type 3 endoleak occurred because of the migration and detachment of the left iliac limb. All 4 patients underwent additional iliac stent graft implantation to connect or reline the iliac limb. RESULTS: The mean diameter of the aneurysms was 85.3 ± 18.9 mm, and 2 patients were diagnosed with ruptured AAAs. The mean diameter, length, and proportional engagement rate of the CIA that experienced migration of the iliac limb were 25.50 ± 11.1 mm, 32.8 ± 6.6 mm, and 72.75% ± 17.88%, respectively. Oversizing of the iliac stent graft was 10-20% in 2 patients and was less than 10% in the other 2 patients. The migrated iliac limbs were bell-bottom stent grafts. All patients underwent additional iliac stent graft implantation successfully, and there were no deaths or complications perioperatively. The patients were followed up from 7 months to 3 years and remained in good condition. CONCLUSIONS: Migration of the iliac limb after EVAR was influenced by a complex combination of several factors including a large aneurysm (>60 mm in diameter), dilated or aneurysmal CIA (>18 mm in diameter), short length of fixation (<70%), lower degree of iliac limb oversizing (<10-20%), and bell-bottom of the iliac limb. Patients with these factors require more vigorous surveillance after EVAR. The implantation of an additional stent graft is effective and is the most common reintervention procedure.
引用
- Wang Y, Li C, Xin H, et al. Predisposing Factors for Migration of the Iliac Limb and Reintervention after Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2019. PMID: 31009727. doi:10.1016/j.avsg.2019.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。